{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hérédité multifactorielle : Questions médicales les plus fréquentes",
"headline": "Hérédité multifactorielle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hérédité multifactorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hérédité multifactorielle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Modes de transmission héréditaire",
"url": "https://questionsmedicales.fr/mesh/D040582",
"about": {
"@type": "MedicalCondition",
"name": "Modes de transmission héréditaire",
"code": {
"@type": "MedicalCode",
"code": "D040582",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.420"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hérédité multifactorielle",
"alternateName": "Multifactorial Inheritance",
"code": {
"@type": "MedicalCode",
"code": "D020412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zexuan Zhu",
"url": "https://questionsmedicales.fr/author/Zexuan%20Zhu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Muhammad Umar Nasir",
"url": "https://questionsmedicales.fr/author/Muhammad%20Umar%20Nasir",
"affiliation": {
"@type": "Organization",
"name": "Riphah School of Computing & Innovation, Faculty of Computing, Riphah International University Lahore Campus, Lahore 54000, Pakistan."
}
},
{
"@type": "Person",
"name": "Mohammed Gollapalli",
"url": "https://questionsmedicales.fr/author/Mohammed%20Gollapalli",
"affiliation": {
"@type": "Organization",
"name": "Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia."
}
},
{
"@type": "Person",
"name": "Muhammad Adnan Khan",
"url": "https://questionsmedicales.fr/author/Muhammad%20Adnan%20Khan",
"affiliation": {
"@type": "Organization",
"name": "Pattern Recognition and Machine Learning Lab, Department of Software, Gachon University, Seongnam, Gyeonggido 13120, Republic of Korea."
}
},
{
"@type": "Person",
"name": "Kord M Kober",
"url": "https://questionsmedicales.fr/author/Kord%20M%20Kober",
"affiliation": {
"@type": "Organization",
"name": "University of California, San Francisco."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Down-regulation of the",
"datePublished": "2023-10-23",
"url": "https://questionsmedicales.fr/article/37871609",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09513590.2023.2269273"
}
},
{
"@type": "ScholarlyArticle",
"name": "Down-Regulation of CYP3A4 by the K",
"datePublished": "2023-10-27",
"url": "https://questionsmedicales.fr/article/37958656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms242115672"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diazepam-Induced Down-Regulation of the GABA",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37356564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neulet.2023.137358"
}
},
{
"@type": "ScholarlyArticle",
"name": "Stretch-Induced Down-Regulation of HCN2 Suppresses Contractile Activity.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37298834",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28114359"
}
},
{
"@type": "ScholarlyArticle",
"name": "Down-regulation of stimulator of interferon genes (STING) expression and CD8",
"datePublished": "2023-08-05",
"url": "https://questionsmedicales.fr/article/37542528",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10120-023-01417-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Modes de transmission héréditaire",
"item": "https://questionsmedicales.fr/mesh/D040582"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hérédité multifactorielle",
"item": "https://questionsmedicales.fr/mesh/D020412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hérédité multifactorielle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hérédité multifactorielle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hérédité multifactorielle",
"description": "Comment diagnostiquer une maladie multifactorielle ?\nQuels tests sont utilisés pour le diagnostic ?\nLes antécédents familiaux sont-ils importants ?\nPeut-on identifier des marqueurs génétiques ?\nQuel rôle joue la génétique dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Down-Regulation#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hérédité multifactorielle",
"description": "Quels sont les symptômes courants des maladies multifactorielle ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLes symptômes sont-ils similaires à d'autres maladies ?\nPeut-on avoir des symptômes sans antécédents familiaux ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Down-Regulation#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hérédité multifactorielle",
"description": "Comment prévenir les maladies multifactorielle ?\nL'éducation génétique aide-t-elle à la prévention ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes changements de mode de vie sont-ils efficaces ?\nLes vaccinations jouent-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Down-Regulation#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hérédité multifactorielle",
"description": "Quels traitements sont disponibles pour les maladies multifactorielle ?\nLes traitements sont-ils personnalisés ?\nY a-t-il des traitements préventifs ?\nLes traitements sont-ils efficaces à long terme ?\nLes traitements peuvent-ils avoir des effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Down-Regulation#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hérédité multifactorielle",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles évitables ?\nLes complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être gérées ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Down-Regulation#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hérédité multifactorielle",
"description": "Quels sont les principaux facteurs de risque ?\nL'alimentation influence-t-elle le risque ?\nLe stress est-il un facteur de risque ?\nL'exercice physique joue-t-il un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?",
"url": "https://questionsmedicales.fr/mesh/D020412?mesh_terms=Down-Regulation#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie multifactorielle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique familial, les tests génétiques et l'évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques, des analyses sanguines et des examens cliniques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à évaluer le risque et à orienter le diagnostic des maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des marqueurs génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs génétiques peuvent indiquer une prédisposition à des maladies spécifiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La génétique aide à comprendre les facteurs héréditaires contribuant à la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies multifactorielle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon la maladie, mais peuvent inclure fatigue, douleurs et anomalies physiques."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes peuvent se manifester à l'enfance, tandis que d'autres apparaissent à l'âge adulte."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à d'autres maladies ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent se chevaucher avec d'autres conditions, rendant le diagnostic complexe."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans antécédents familiaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux peuvent également déclencher des symptômes sans antécédents héréditaires."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies multifactorielle ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, des dépistages réguliers et la gestion des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'éducation génétique aide-t-elle à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques génétiques peut aider les individus à prendre des décisions éclairées."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests peuvent identifier les personnes à risque et orienter les mesures préventives."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, adopter un mode de vie sain peut réduire le risque de développer certaines maladies."
}
},
{
"@type": "Question",
"name": "Les vaccinations jouent-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies multifactorielle ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des thérapies physiques et des interventions chirurgicales selon la maladie."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des caractéristiques génétiques et des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions préventives peuvent réduire le risque, comme des changements de mode de vie et des dépistages."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon la maladie et le traitement, nécessitant un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils avoir des effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comme tout traitement, il peut y avoir des effets secondaires qui doivent être surveillés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications varient selon la maladie, mais peuvent inclure des problèmes chroniques et des handicaps."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles évitables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et une gestion appropriée."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses complications peuvent être gérées avec des traitements appropriés et un suivi."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies multifactorielle peuvent entraîner des complications à long terme nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hérédité, l'environnement, le mode de vie et des conditions médicales préexistantes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut augmenter le risque de certaines maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à l'apparition de maladies multifactorielle."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque d'exercice peut augmenter le risque de développer certaines maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils significatifs ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des polluants peut augmenter le risque de maladies multifactorielle."
}
}
]
}
]
}
Department of Computer Information Systems, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Division of Plant Sciences and Interdisciplinary Plant Group, College of Agriculture, Food and Natural Resources, Christopher S. Bond Life Sciences Center, University of Missouri, 1201 Rollins Street, Columbia, MO, 65201, USA.
Pediatric Neurology Unit, Department of Pediatrics, Navarra Health Service Hospital, Irunlarrea 4, 310620 Pamplona, Spain; Navarrabiomed-Miguel Servet Research Foundation, Pamplona, Spain.
Neurometabolic Diseases Laboratory, IDIBELL, Hospital Duran i Reynals, Gran Via 199, 08908, L'Hospitalet de Llobregat, Barcelona, Spain; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain; Center for Biomedical Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain. Electronic address: apujol@idibell.cat.
School of Information Technology, Skyline University College, Sharjah 1797, UAE.
Network and Communication Technology Lab, Center for Cyber Security, Faculty of Information Science and Technology, Universiti Kebangsaan, Malaysia 43600, Malaysia.
Department of Computer Science, College of Computer Science and Information Technology, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Computer Science (CS), College of Computer Science and Information Technology (CCSIT), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
Department of Computer, Deanship of Preparatory Year and Supporting Studies, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia.
To evaluate FTO concentrations in follicular fluid (FF) of women with ovarian endometriosis (OE) and controls women without OE undergoing...
FTO concentrations in FF were measured in 74 patients (37 in the control group and 37 in the OE group) by ELISA. We measured the expression of FTO in GCs of 40 patients (19 in the control group and 21...
Compared with the control group, FTO concentrations in FF (6.92 ± 0.44...
The FTO concentrations in FF of infertility women with OE are decreased, which may be related to the impaired oocyte quality in endometriosis patients....
Benzodiazepines are among the most prescribed drug class worldwide to treat disorders such as anxiety, insomnia, muscle spasticity, and convulsive disorders, and to induce presurgical sedation. Althou...
Although hyperpolarization-activated and cyclic nucleotide-gated 2 channels (HCN2) are expressed in multiple cell types in the gut, the role of HCN2 in intestinal motility is poorly understood. HCN2 i...
HER2 signaling might be involved in the regulation of immune cell activation in the tumor microenvironment (TME) of gastric cancer (GC). However, the relationship between HER2 status and immune cell c...
To investigate the effect of HER2 signaling on the activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, which contributes to immune cell activation in the G...
The expression of HER2 is highly heterogeneous in HER2-positive GC tissues, and we found that the number of CD8...
Our results suggest that HER2 signaling might suppress immune cell activation in the GC TME by inhibiting STING signaling in tumor cells in HER2-positive GC....
Biofilm formation is the major pathogenicity of...
The inhibiting mechanisms of isookanin against biofilm formation through surface hydrophobicity assay, exopolysaccharides, eDNA, gene expression analysis, microscopic visualization, and molecular dock...
The results showed that isookanin could decrease the biofilm formation of...
This study improved the antibiotic susceptibility of...
Pathogenic variants in the transcription factor CCCTC-binding factor (CTCF) are associated with mental retardation, autosomal dominant 21 (MRD21, MIM#615502). Current studies supported the strong rela...
Anoikis, a form of apoptosis resulting from the loss of cell-extracellular matrix interaction, is a significant barrier to cancer cell metastasis. However, the epigenetic regulation of this process re...
Pancreatic ductal adenocarcinoma (PDAC) is associated with a very poor prognosis. Therefore, there has been a focus on identifying new biomarkers for its early diagnosis and the prediction of patient ...
Overexpression of lysophosphatidylcholine acyltransferase 1 (LPCAT1) has been found in various solid cancers and is associated with disease progression, metastasis, and recurrence. However, the expres...
LPCAT1 expression in bone marrow was significantly lower in AML than in healthy controls predicted by public databases. Furthermore, real-time quantitative PCR (RQ-PCR) validated that LPCAT1 expressio...
LPCAT1 is down-regulated in AML bone marrow, and LPCAT1 down-regulation could be used as a potential biomarker for AML diagnosis and prognosis....